These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 33319774)

  • 1. Studying pre-treatment and ketamine-induced changes in white matter microstructure in the context of ketamine's antidepressant effects.
    Sydnor VJ; Lyall AE; Cetin-Karayumak S; Cheung JC; Felicione JM; Akeju O; Shenton ME; Deckersbach T; Ionescu DF; Pasternak O; Cusin C; Kubicki M
    Transl Psychiatry; 2020 Dec; 10(1):432. PubMed ID: 33319774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in white matter microstructure following serial ketamine infusions in treatment resistant depression.
    Taraku B; Woods RP; Boucher M; Espinoza R; Jog M; Al-Sharif N; Narr KL; Zavaliangos-Petropulu A
    Hum Brain Mapp; 2023 Apr; 44(6):2395-2406. PubMed ID: 36715291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine's antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorder.
    Niciu MJ; Luckenbaugh DA; Ionescu DF; Richards EM; Vande Voort JL; Ballard ED; Brutsche NE; Furey ML; Zarate CA
    Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression.
    Xu AJ; Niciu MJ; Lundin NB; Luckenbaugh DA; Ionescu DF; Richards EM; Vande Voort JL; Ballard ED; Brutsche NE; Machado-Vieira R; Zarate CA
    Neural Plast; 2015; 2015():858251. PubMed ID: 26137324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Habenula Connectivity and Intravenous Ketamine in Treatment-Resistant Depression.
    Rivas-Grajales AM; Salas R; Robinson ME; Qi K; Murrough JW; Mathew SJ
    Int J Neuropsychopharmacol; 2021 May; 24(5):383-391. PubMed ID: 33249434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age affects temporal response, but not durability, to serial ketamine infusions for treatment refractory depression.
    Pennybaker S; Roach BJ; Fryer SL; Badathala A; Wallace AW; Mathalon DH; Marton TF
    Psychopharmacology (Berl); 2021 Nov; 238(11):3229-3237. PubMed ID: 34363507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study.
    Carlson PJ; Diazgranados N; Nugent AC; Ibrahim L; Luckenbaugh DA; Brutsche N; Herscovitch P; Manji HK; Zarate CA; Drevets WC
    Biol Psychiatry; 2013 Jun; 73(12):1213-21. PubMed ID: 23540908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to Prolong Ketamine's Efficacy in Adults with Treatment-Resistant Depression.
    McMullen EP; Lee Y; Lipsitz O; Lui LMW; Vinberg M; Ho R; Rodrigues NB; Rosenblat JD; Cao B; Gill H; Teopiz KM; Cha DS; McIntyre RS
    Adv Ther; 2021 Jun; 38(6):2795-2820. PubMed ID: 33929660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review.
    du Jardin KG; Müller HK; Elfving B; Dale E; Wegener G; Sanchez C
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():27-38. PubMed ID: 27262695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ketamine's antidepressant effect: focus on ketamine mechanisms of action].
    De Maricourt P; Jay T; Goncalvès P; Lôo H; Gaillard R
    Encephale; 2014 Feb; 40(1):48-55. PubMed ID: 24434007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine's rapid antisuicidal effects are not attenuated by Buprenorphine.
    Hosanagar A; Schmale A; LeBlanc A
    J Affect Disord; 2021 Mar; 282():252-254. PubMed ID: 33418374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic signatures of intravenous racemic ketamine associated remission in treatment-resistant depression: A pilot hypothesis generating study.
    Singh B; MahmoudianDehkordi S; Voort JLV; Han X; Port JD; Frye MA; Kaddurah-Daouk R;
    Psychiatry Res; 2022 Aug; 314():114655. PubMed ID: 35738038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural complexity EEG biomarkers of rapid and post-rapid ketamine effects in late-life treatment-resistant depression: a randomized control trial.
    Murphy N; Tamman AJF; Lijffijt M; Amarneh D; Iqbal S; Swann A; Averill LA; O'Brien B; Mathew SJ
    Neuropsychopharmacology; 2023 Oct; 48(11):1586-1593. PubMed ID: 37076582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketamine for depression.
    Jelen LA; Stone JM
    Int Rev Psychiatry; 2021 May; 33(3):207-228. PubMed ID: 33569971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural connectivity and response to ketamine therapy in major depression: A preliminary study.
    Vasavada MM; Leaver AM; Espinoza RT; Joshi SH; Njau SN; Woods RP; Narr KL
    J Affect Disord; 2016 Jan; 190():836-841. PubMed ID: 26630613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between peripheral inflammation and free-water imaging in Major Depressive Disorder before and after ketamine treatment - A pilot study.
    Langhein M; Seitz-Holland J; Lyall AE; Pasternak O; Chunga N; Cetin-Karayumak S; Kubicki A; Mulert C; Espinoza RT; Narr KL; Kubicki M
    J Affect Disord; 2022 Oct; 314():78-85. PubMed ID: 35779673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial.
    Dwyer JB; Landeros-Weisenberger A; Johnson JA; Londono Tobon A; Flores JM; Nasir M; Couloures K; Sanacora G; Bloch MH
    Am J Psychiatry; 2021 Apr; 178(4):352-362. PubMed ID: 33653121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neural connectivity moderators and mechanisms of ketamine treatment among treatment-resistant depressed patients: a randomized controlled trial.
    Rengasamy M; Mathew S; Howland R; Griffo A; Panny B; Price R
    EBioMedicine; 2024 Jan; 99():104902. PubMed ID: 38141395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
    Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
    J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White Matter Microstructure Associated with the Antidepressant Effects of Deep Brain Stimulation in Treatment-Resistant Depression: A Review of Diffusion Tensor Imaging Studies.
    Cattarinussi G; Moghaddam HS; Aarabi MH; Squarcina L; Sambataro F; Brambilla P; Delvecchio G
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.